Loading…
India Infra Updates on WhatsApp
Join the Tenderkart WhatsApp channel for India Tender Updates
Loading…
Tender ID
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Company | Status |
|---|---|---|
| 1 | Admitted-Fee/PreQual/Technical | Admitted-Fee/PreQual/Technical |
| 2 | Admitted-Fee/PreQual/Technical 202 AGARWAL PLAZA PLOT NO 3 DDA COMPLEX SECTOR 14 PRASHANT VIHAR ROHINI 85 NEW DELHI DELHI INDIA 110085 | NEW DELHI | NORTH WEST DELHI | DELHI | 110085 | Admitted-Fee/PreQual/Technical |
| 3 | Admitted-Fee/PreQual/Technical | Admitted-Fee/PreQual/Technical |
Tender Value
₹448 Cr
EMD Value
₹4 Cr
Closing Date
1 Jun 2023, 4:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
DG and CEO CMSS
CMSS New Delhi
Online tender for rate contract for a period of One year for Procurement of Tablet Rifapentine 300mg and Isoniazid 300mg for NTEP.
2023_CMSS_751346_1
CMSS/PROC/2023-24/NTEP/008
Open Tender
Drugs and Pharmaceutical Products
Supply
90 days
CMSS New Delhi
As per tender documents
2 documents required · 2 mandatory
₹0
₹4 Cr
Yes
CMSS New Delhi
27 Jun 2023
1 May 2023
2 Jun 2023
1 May 2023
1 Jun 2023
15 May 2023
1 May 2023 - 8 May 2023
8 May 2023
stage.html
html • 0.03 MB
tech_bid_open.pdf
cancelled_1.pdf
pdf • 0.13 MB
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.30 MB
BOQ_789943.xls
BOQ • 0.24 MB
TED008.pdf
Tender Documents • 4.70 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .